Skip to content
Lower risk Drug recall · FDA · Published August 17, 2026

Mylan Prasugrel Tablets Recall: Failed Stability Testing Risk

Mylan recalls 10mg Prasugrel tablets that failed 18-month stability testing. These tablets may not be safe for long-term use. Consumers should contact Mylan for details.

🇺🇸 FDA recall #D-0839-2026DrugMylan ›
✎ GovInfoNow plain-language explainer

Mylan is recalling 10mg Prasugrel tablets that failed stability testing. This means the tablets might not be safe for long-term use, so they should not be taken without consulting a healthcare provider. Read more at govinfonow.com/recall/1004698-mylan-prasugrel-tablets-recall-failed-stability-testing-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/1004698-mylan-prasugrel-tablets-recall-failed-stability-testing-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0839-2026

Cite this page

“Mylan Prasugrel Tablets Recall: Failed Stability Testing Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/1004698-mylan-prasugrel-tablets-recall-failed-stability-testing-risk. Based on FDA recall #D-0839-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0839-2026%22&limit=1).

The FDA announced on August 17, 2026, that Mylan Pharmaceuticals Inc. is recalling Prasugrel Tablets, USP, 10mg due to failed dissolution specifications. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Mylan
  • Product: Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle
  • NDC: 0378-5186-93
  • Lot #: 3225272
  • Expiration Date: September 30, 2026
  • Quantity: 47,662 bottles

The hazard

The product failed to meet 18-month stability testing acceptance criteria. The FDA stated the hazard is failed dissolution specifications.

Context

GovInfoNow's records show Mylan Pharmaceuticals Inc. has 54 other recalls on record since June 28, 2012. Other recent recalls of similar products include Mylan Mycophenolate Mofetil Injections (August 26, 2026), Mylan Acamprosate Tablets (July 24, 2026), and Mylan Mycophenolate Mofetil Injection (July 2, 2026). Other recent recalls of similar products include Apotex Paxil CR 37.5mg Tablets (August 13, 2026), Golden State Medical Prasugrel HCl 10mg Tablets (August 21, 2026), and Cipla Phytonadione Injectable Emulsion (October 31, 2025).

How to tell if you have this one

Check for the lot number 3225272 on the bottle. The product was made in India and expires September 30, 2026.

  • Brand
    Mylan
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Mylan

    Reach out to Mylan Pharmaceuticals for specific instructions on what to do with the recalled tablets.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 23 days after the firm started it.

1. Firm started the recall: Aug 17, 202612. Published in FDA’s Enforcement Report: Sep 9, 202623. FDA classified it Class II: Sep 11, 202634. Added to GovInfoNow: Sep 23, 202642026
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class II
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Mylan recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0839-2026 (August 17, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0839-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA